Powell Lab at Penn

Powell Lab at Penn

Share

Photos 07/04/2020

Daniel Powell, PhD, Associate Professor in the Department of Pathology & Laboratory Medicine & the Department of Obstetrics & Gynecology at UPENN and an international expert in translational immunotherapy will be our guest speaker in our Virtual Ovarian Cancer Support Group Meeting this Friday at 2 pm EST. He’ll be giving an update on ovarian cancer research. If you would like to attend, please email Jennie at [email protected]. This pic is from the Sandy Sprint Philly. Dan is a team captain. His shirt is very fitting since he’s one of our superheroes!

Quantitative Control of Gene-Engineered T cell Activity Through Covalent Attachment of Targeting Ligands to a Universal Immune Receptor 25/03/2020

Our newest paper from the lab, from recent graduate Dr. Nicholas Minutolo.

Quantitative Control of Gene-Engineered T cell Activity Through Covalent Attachment of Targeting Ligands to a Universal Immune Receptor Universal immune receptors represent a rapidly emerging form of adoptive T cell therapy with the potential to overcome safety and antigen escape challenges faced by conventional chimeric antigen receptor (CAR) T cell therapy. By decoupling antigen recognition and T cell signaling domains via bifunct...

An autologous humanized patient-derived-xenograft platform to evaluate immunotherapy in ovarian cancer 12/12/2019

The latest paper to come out from the Powell Lab!

An autologous humanized patient-derived-xenograft platform to evaluate immunotherapy in ovarian cancer The aim of this study was to “humanize” ovarian cancer patient-derived xenograft (PDX) models by autologous transfer of patient-matched tumor infiltra…

07/10/2019

Powell lab bonding at the Carl June Solid Tumors Beware Party 🎃👻🕷️🕸️🎉

17/12/2018

Happy Holidays from the Powell Lab!

Sandy Sprint 2018 25/04/2018

Some photos from this past weekend at the Sandy Sprint with Sandy Rollman Ovarian Cancer Foundation, Inc.

Ovarian cancer vaccine shows promising results in human study 17/04/2018

A great article from CNN about a personalized immunotherapy trial that was developed at Penn!

Ovarian cancer vaccine shows promising results in human study A personalized cancer vaccine lengthened the lives of patients with ovarian cancer, a small clinical trial demonstrated.